Clinical trial

Bevacizumab, Radiation Therapy, and Cisplatin in Treating Patients With…

NCT00369122 · National Cancer Institute (NCI), NIH · Completed

Key facts

NCT number NCT00369122
Title Bevacizumab, Radiation Therapy, and Cisplatin in Treating Patients With Previously Untreated Locally Advanced Cervical Cancer
Official title A PHASE II STUDY OF BEVACIZUMAB IN COMBINATION WITH DEFINITIVE RADIOTHERAPY AND CISPLATIN CHEMOTHERAPY IN UNTREATED PATIENTS WITH LOCALLY ADVANCED CERVICAL CARCINOMA
Lead sponsor National Cancer Institute (NCI), NIH
Collaborators Radiation Therapy Oncology Group
Status Completed
Phase Phase 2
Study type Interventional
Conditions Cervical Adenocarcinoma, Cervical Adenosquamous Carcinoma, Cervical Squamous Cell Carcinoma, Not Otherwise Specified, Stage IB Cervical Cancer AJCC v6 and v7, Stage IIA Cervical Cancer AJCC v7, Stage IIB Cervical Cancer AJCC v6 and v7, Stage III Cervical Cancer AJCC v6 and v7
Intervention type Biological, Drug, Radiation
Interventions Bevacizumab, Cisplatin, External Beam Radiation Therapy, Internal Radiation Therapy
Enrollment 60
Start date Aug 11, 2006
Primary completion Jun 4, 2010
Completion Dec 15, 2016
First posted Aug 29, 2006
Last update posted Mar 20, 2018
Countries Canada, United States

At a glance

  • 100–999 Study sites
  • Yes Results posted
  • None Linked FDA submissions

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About ClinicalTrials.gov studies

ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.

Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date:

Browse all ClinicalTrials.gov studies